AMARIN CORP PLC\UK Payments for (Proceeds from) Other Investing Activities
AMARIN CORP PLC\UK (AMRN) reported Payments for (Proceeds from) Other Investing Activities of -$700.00 thousand for the 12-month period ending 2009-12-31, per its 10-K filed 2012-02-29.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsForProceedsFromOtherInvestingActivities · last filed 2012-02-29
- AMARIN CORP PLC\UK payments for (proceeds from) other investing activities for fiscal 2009 was -$700.00K.
| Period end | Payments for (Proceeds from) Other Investing Activities 12 month |
|---|---|
| 2009-12-31 | -$700.00K 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |